Study details
Enrolling now
Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial
Mayo Clinic
NCT IDNCT06438588ClinicalTrials.gov data as of Apr 2026
Target enrollment
10
Study length
about 3 years
Ages
18+
Locations
1 site in FL
About this study
This trial is testing a fast mimicking diet (FMD) to reduce side effects from cancer treatments in patients taking immune checkpoint inhibitors. The FMD involves eating a special diet that mimics fasting and helps protect against common side effects like skin rash, diarrhea, and fatigue.
Based on ClinicalTrials.gov records.
What participants do
- 1.Dietary Intervention
- 2.Educational Intervention
- 3.Electronic Health Record Review
- +3 more
Primary goalIncidence of adverse events
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Incidence of adverse events, Physical function, Quality of life - FACT-G, Symptom Measurement
Procedures
diagnostic